These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26785065)

  • 1. Optimal management of bone mineral disorders in chronic kidney disease and end stage renal disease.
    Lundquist AL; Nigwekar SU
    Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):120-6. PubMed ID: 26785065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic kidney disease: mineral and bone disorder in children.
    Wesseling-Perry K; Salusky IB
    Semin Nephrol; 2013 Mar; 33(2):169-79. PubMed ID: 23465503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in the therapy of secondary hyperparathyroidism.
    Wood C; González EA; Martin KJ
    Ther Apher Dial; 2005 Feb; 9(1):4-8. PubMed ID: 15828898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineral metabolism and bone abnormalities in children with chronic renal failure.
    Sanchez CP
    Rev Endocr Metab Disord; 2008 Jun; 9(2):131-7. PubMed ID: 18175221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.
    Molony DA; Stephens BW
    Adv Chronic Kidney Dis; 2011 Mar; 18(2):120-31. PubMed ID: 21406297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of bone and mineral related disorders in chronic kidney disease: key role of hyperphosphatemia.
    Román-García P; Carrillo-López N; Cannata-Andía JB
    J Ren Care; 2009 Mar; 35 Suppl 1():34-8. PubMed ID: 19222729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.).
    Torregrosa JV; Bover J; Cannata Andía J; Lorenzo V; de Francisco AL; Martínez I; Rodríguez Portillo M; Arenas L; González Parra E; Caravaca F; Martín-Malo A; Fernández Giráldez E; Torres A;
    Nefrologia; 2011; 31 Suppl 1():3-32. PubMed ID: 21468161
    [No Abstract]   [Full Text] [Related]  

  • 8. The uses and abuses of Vitamin D compounds in chronic kidney disease-mineral bone disease (CKD-MBD).
    Goldsmith DJ; Massy ZA; Brandenburg V
    Semin Nephrol; 2014 Nov; 34(6):660-8. PubMed ID: 25498384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Direct effects of vitamin D on bone].
    Kazama JJ
    Clin Calcium; 2004 Sep; 14(9):27-30. PubMed ID: 15577106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary hyperparathyroidism in chronic kidney disease: clinical consequences and challenges.
    Michael M; Garcia D
    Nephrol Nurs J; 2004; 31(2):185-94; quiz 195-6. PubMed ID: 15114799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic kidney disease--mineral and bone disorder: why and how to control phosphate].
    Pavlović D; Katicić D; Josipović J
    Acta Med Croatica; 2012 Oct; 66 Suppl 2():64-7. PubMed ID: 23513419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic renal failure causes bone fragility and blood vessel stiffening].
    Keronen S; Martola L; Honkanen E
    Duodecim; 2012; 128(5):465-74. PubMed ID: 22486062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy for the altered mineral metabolism of chronic kidney disease: implications for vascular calcification.
    Saab G; Whaley-Connell AT; Khanna R; Sowers JR
    Ther Adv Cardiovasc Dis; 2007 Dec; 1(2):107-12. PubMed ID: 19124399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure.
    Cozzolino M; Gallieni M; Brancaccio D; Arcidiacono T; Bianchi G; Vezzoli G
    J Nephrol; 2006; 19(5):566-77. PubMed ID: 17136683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Battleground: chronic kidney disorders mineral and bone disease--calcium obsession, vitamin d, and binder confusion.
    Kovesdy CP; Mehrotra R; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):168-73. PubMed ID: 18045858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vitamin D metabolism and chronic kidney disease].
    Honda H; Sanada D; Akizawa T
    Clin Calcium; 2006 Jul; 16(7):1143-46. PubMed ID: 16816474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of mineral and bone disorder in chronic kidney disease: quo vadis?
    Nakai K; Komaba H; Fukagawa M
    Ther Apher Dial; 2009 Oct; 13 Suppl 1():S2-6. PubMed ID: 19765254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone disease in chronic renal failure and its modern therapy].
    Dusilová Sulková S
    Vnitr Lek; 2011; 57(7-8):620-5. PubMed ID: 21877595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of mineral and bone disorders in chronic kidney disease (CKD-MBD) in adults.
    Bellorin-Font E; Ambrosoni P; Carlini RG; Carvalho AB; Correa-Rotter R; Cueto-Manzano A; Jara A; Jorgetti V; Negri AL; Olaizola I; Salusky I; Slatopolsky E; Weisinger JR; ;
    Nefrologia; 2013; 33 Suppl 1():1-28. PubMed ID: 23629678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An introduction to CKD-MBD research: restart for the future.
    Fukagawa M; Inaba M; Yokoyama K; Shigematsu T; Ando R; Miyamoto KI;
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):1-3. PubMed ID: 28083765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.